Sign up to save your podcasts
Or
Share Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.
H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.
View all episodes
By UEG Journal
5
33 ratings
H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.
H. Tarik Kani talks to Dr Samuel Raimundo Fernandes (Portugal) about his recent paper about impact of transmural remission on clinical outcomes in Crohn's disease which was a multicenter study evaluated the clinical outcomes up to 5 years.
More shows like UEG Journal
View all
American Journal of Gastroenterology Author Podcasts
68 Listeners